BRD1
Basic information
Region (hg38): 22:49773278-49827873
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BRD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 20 | ||||
missense | 61 | 72 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 61 | 20 | 11 |
Variants in BRD1
This is a list of pathogenic ClinVar variants found in the BRD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-49774254-G-A | Likely benign (May 21, 2018) | |||
22-49774268-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
22-49774275-G-A | Likely benign (Dec 27, 2017) | |||
22-49774298-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
22-49774367-T-C | not specified | Uncertain significance (May 27, 2022) | ||
22-49775658-C-G | not specified | Uncertain significance (Feb 14, 2025) | ||
22-49775663-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
22-49775668-C-T | Likely benign (Feb 01, 2023) | |||
22-49775674-G-T | not specified | Uncertain significance (Dec 28, 2024) | ||
22-49775698-G-C | Benign (May 30, 2018) | |||
22-49775700-C-T | not specified | Uncertain significance (Feb 25, 2025) | ||
22-49775724-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
22-49776066-G-C | not specified | Uncertain significance (Jan 22, 2025) | ||
22-49776122-G-A | Benign (Jan 04, 2019) | |||
22-49776148-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
22-49776153-C-G | not specified | Uncertain significance (Oct 20, 2023) | ||
22-49776154-C-T | not specified | Uncertain significance (Jan 23, 2025) | ||
22-49776163-C-T | Likely benign (Sep 20, 2018) | |||
22-49777040-C-T | not specified | Uncertain significance (Jul 07, 2022) | ||
22-49777081-G-A | not specified | Uncertain significance (May 30, 2024) | ||
22-49777093-C-G | not specified | Uncertain significance (Nov 14, 2023) | ||
22-49777094-T-C | not specified | Uncertain significance (Feb 27, 2025) | ||
22-49777095-G-A | Benign (Jan 04, 2019) | |||
22-49777096-C-T | not specified | Uncertain significance (Aug 23, 2021) | ||
22-49777115-G-A | not specified | Uncertain significance (Jan 19, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BRD1 | protein_coding | protein_coding | ENST00000216267 | 12 | 54230 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000513 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 501 | 708 | 0.708 | 0.0000506 | 6920 |
Missense in Polyphen | 126 | 293.14 | 0.42983 | 2871 | ||
Synonymous | -2.34 | 369 | 316 | 1.17 | 0.0000256 | 2115 |
Loss of Function | 5.64 | 6 | 48.3 | 0.124 | 0.00000291 | 495 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.000163 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:21880731}.;
- Pathway
- Pathways Affected in Adenoid Cystic Carcinoma;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization;Regulation of TP53 Activity through Acetylation;Regulation of TP53 Activity;Transcriptional Regulation by TP53
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.350
- rvis_EVS
- -1.72
- rvis_percentile_EVS
- 2.49
Haploinsufficiency Scores
- pHI
- 0.569
- hipred
- Y
- hipred_score
- 0.649
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.796
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Brd1
- Phenotype
- cellular phenotype; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); liver/biliary system phenotype; embryo phenotype;
Gene ontology
- Biological process
- response to immobilization stress;histone H3 acetylation;response to electrical stimulus
- Cellular component
- nucleus;nuclear speck;dendrite;perikaryon;MOZ/MORF histone acetyltransferase complex
- Molecular function
- histone binding;metal ion binding